Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Chaouat

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
The European Respiratory Journal|March 21, 2024
Pulmonary vascular phenotype identified in patients with <i>GDF2</i> (<i>BMP9</i>) or <i>BMP10</i> variants: an international multicentre studyJulien Grynblat, Harm Jan Bogaard, Mélanie Eyries, et al.
The European Respiratory Journal|November 24, 2017
An official European Respiratory Society statement: pulmonary haemodynamics during exerciseGabor Kovacs, Philippe Herve, Joan Albert Barbera, et al.
The European Respiratory Journal|May 26, 2022
An emerging phenotype of pulmonary arterial hypertension patients carrying <i>SOX17</i> variantsDavid Montani, Benoit Lechartier, Barbara Girerd, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 5, 2021
Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohortGaëlle Dauriat, Martine Reynaud-Gaubert, Vincent Cottin, et al.
The European Respiratory Journal|January 15, 2021
Serum and pulmonary uric acid in pulmonary arterial hypertensionLaurent Savale, Satoshi Akagi, Ly Tu, et al.
Circulation|June 30, 2010
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management eraMarc Humbert, Olivier Sitbon, Ari Chaouat, et al.
The European Respiratory Journal|February 22, 2020
Phenotype and outcome of pulmonary arterial hypertension patients carrying a <i>TBX4</i> mutationPierre Thoré, Barbara Girerd, Xavier Jaïs, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.
Respiratory Medicine and Research|October 31, 2025
Evolving paradigms in pulmonary hypertension: Highlights of the 6<sup>th</sup> French Pulmonary Hypertension Network MeetingAthénaïs Boucly, Antoine Beauvais, Thomas Lacoste-Palasset, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
The European Respiratory Journal|March 21, 2024
Pulmonary vascular phenotype identified in patients with <i>GDF2</i> (<i>BMP9</i>) or <i>BMP10</i> variants: an international multicentre studyJulien Grynblat, Harm Jan Bogaard, Mélanie Eyries, et al.
The European Respiratory Journal|November 24, 2017
An official European Respiratory Society statement: pulmonary haemodynamics during exerciseGabor Kovacs, Philippe Herve, Joan Albert Barbera, et al.
The European Respiratory Journal|May 26, 2022
An emerging phenotype of pulmonary arterial hypertension patients carrying <i>SOX17</i> variantsDavid Montani, Benoit Lechartier, Barbara Girerd, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 5, 2021
Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohortGaëlle Dauriat, Martine Reynaud-Gaubert, Vincent Cottin, et al.
The European Respiratory Journal|January 15, 2021
Serum and pulmonary uric acid in pulmonary arterial hypertensionLaurent Savale, Satoshi Akagi, Ly Tu, et al.
Circulation|June 30, 2010
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management eraMarc Humbert, Olivier Sitbon, Ari Chaouat, et al.
The European Respiratory Journal|February 22, 2020
Phenotype and outcome of pulmonary arterial hypertension patients carrying a <i>TBX4</i> mutationPierre Thoré, Barbara Girerd, Xavier Jaïs, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
The European Respiratory Journal|January 30, 2025
Initial therapy in patients with pulmonary arterial hypertension and cardiovascular comorbiditiesAthénaïs Boucly, David Montani, Fabrice Bauer, et al.
Respiratory Medicine and Research|October 31, 2025
Evolving paradigms in pulmonary hypertension: Highlights of the 6<sup>th</sup> French Pulmonary Hypertension Network MeetingAthénaïs Boucly, Antoine Beauvais, Thomas Lacoste-Palasset, et al.
Pageof 11